Boston, MA – STAT, a leading publication covering biopharma, health, and life sciences, has announced a significant discount on its annual subscription for a broad range of professionals and students....
London, UK – Bio Protocol, a biotech financial platform, has unveiled a new governance proposal on ResearchHub to fund a pioneering study into psilocybin's neuroprotective role in stroke. The initiati...
Palo Alto, CA – Paul Graham, co-founder of Y Combinator, recently highlighted a significant trend within the startup accelerator's portfolio: multiple companies are developing cancer cures that are ne...
Recent research indicates that a single dose of psilocybin, the psychoactive compound found in certain mushrooms, can induce significant and sustained changes in brain function, leading to improvement...
Bio Protocol has announced the commencement of the Ignition Sale for Aubrai, its inaugural BioAgent project, beginning this Monday. The 24-hour fixed-price sale, hosted on the Bio launchpad, sets Aubr...
A significant new resource for artificial intelligence in drug discovery, DynaRepo, has been announced, providing an unprecedented collection of molecular dynamics (MD) simulation data. The repositor...
Leading epigenetics researcher Jacob Kimmel has outlined three key evolutionary complications that explain why natural selection has not optimized for extended human lifespans, despite the potential f...
**Boston, MA** – The pharmaceutical industry is increasingly looking to advanced preclinical models, such as organ chips, to mitigate the high failure rates and significant costs associated with drug ...
San Francisco, CA – Convoke, a company focused on developing AI tools for the biopharmaceutical industry, has successfully closed an $8.6 million seed financing round. The funding was led by prominent...
Silicon Valley-based company Orchid, founded by Noor Siddiqui, is at the forefront of a burgeoning field, offering comprehensive genetic screening for embryos to prospective parents. The company aims ...
A public discussion hosted by Interintellect, featuring political philosopher Adam Gjesdal and bioethicist Dr. Jonathan Anomaly, is set to delve into the burgeoning field of trait-based embryo selecti...
The escalating incidence of cancer with advancing age is a well-documented phenomenon, with rates climbing dramatically from young adulthood into senior years. This significant increase is primarily a...
Recent scientific advancements, particularly in gene editing, are bringing renewed hope for a potential cure for Progeria, a rare genetic disorder that causes rapid, premature aging in children. The N...
San Francisco, CA – Noor Siddiqui, CEO of biotech startup Orchid Health, has boldly declared that her company's advanced whole-genome embryo screening will become the "default way smart parents have b...
Cambridge, MA – Researchers at the Massachusetts Institute of Technology (MIT) have successfully designed novel antibiotics using artificial intelligence (AI) that show promise against two difficult-t...
UCLA researchers have developed a novel CAR-NKT cell therapy that demonstrated 100% efficacy in preclinical tests against ovarian cancer, including chemo-resistant tumors. The breakthrough, led by Dr....
Ruxandra Teslo, a prominent voice in science and innovation, recently highlighted a significant barrier to progress in the biotechnology sector: the lack of public access to regulatory filings. In a r...
Ruxandra Teslo, a prominent voice in the biotech sector, recently highlighted a significant challenge for emerging biotechnology companies: navigating the complex U.S. Food and Drug Administration (FD...
A translational scientist recently encountered a significant setback in a clinical trial, losing approximately 89% of critical flow cytometry specimens due to preservation issues. The incident, shared...
A recent grant application focusing on cellular rejuvenation, submitted by prominent biogerontologist João Pedro de Magalhães, received feedback that highlighted a significant ethical divide within th...
The U.S. Food and Drug Administration (FDA) has granted approval to SetPoint Medical's SetPoint System, a pioneering neuroimmune modulation device designed for the treatment of moderate-to-severe rheu...
Discussions surrounding embryo selection within academic and conference settings are predominantly focused on ethical challenges and inherent limitations, rather than perceived benefits or widespread ...
San Francisco-based biotech firm NewLimit, co-founded by Coinbase CEO Brian Armstrong, has recently raised $130 million in Series B funding. This significant investment aims to accelerate the company'...
A specific genetic mutation, known as CCR5-Δ32, renders some individuals resistant to common strains of HIV-1 by disabling a crucial immune cell receptor that the virus typically exploits for entry. ...
Menlo Park, California – Andreessen Horowitz (a16z) Bio + Health has partnered with pharmaceutical giant Eli Lilly and Company to establish a new $500 million venture capital fund. Named the Biotech E...
A growing body of scientific research is underscoring the profound influence of gut bacteria on metabolic syndrome, a cluster of conditions including diabetes and cardiovascular issues. Renowned scien...
Pearl Freier, President of Cambridge BioPartners, a strategic advisory firm in the biopharmaceutical and healthcare technology industries, recently voiced concerns regarding the U.S. Food and Drug Adm...
China is significantly accelerating its investment in university-level biotechnology, a trend observed to be gaining momentum partly due to recent funding difficulties experienced by the U.S. National...
**New York, NY** – The intricate connection between mitochondrial health and egg quality is gaining significant attention in the field of reproductive science, with experts highlighting its crucial ro...
Cambridge, MA, and Austin, TX – A recent tweet by Pearl Freier has ignited discussion regarding corporate governance within the biotech sector, specifically highlighting the dual board membership of R...
Vancouver, Canada – NewLimit, a biotechnology company focused on extending human healthspan, has announced a significant advancement in its AI-driven epigenetic reprogramming research, demonstrating a...
Researchers at the National Cancer Center in Tokyo have identified a novel gut bacterium, Hominenteromicrobium strain YB328, that significantly enhances the effectiveness of PD-1 blockade immunotherap...
University of Pennsylvania researchers have achieved a significant breakthrough in the fight against antibiotic resistance, utilizing an artificial intelligence (AI) system named APEX to identify and ...
Researchers have introduced a novel scientific model, dubbed "Cell Annealing," designed to deepen the understanding of cellular aging and rejuvenation processes. Announced by "Dr Singularity" on socia...
Recent high-resolution video footage captured by cell biologist Alex Ritter of RitterLab vividly demonstrates a killer T cell of the immune system actively destroying a monstrous ovarian cancer cell. ...
A recent social media post by "Dr. Shelby" has spotlighted ten biotechnology companies operating at the forefront of scientific innovation, often navigating complex ethical and legal landscapes. The t...
Centivax, a biotechnology firm focused on durable and universal vaccines, has successfully closed an oversubscribed $45 million Series A funding round. The investment was led by Steve Jurvetson's Futu...
The efficacy of plasmapheresis in reversing human biological aging is currently yielding contradictory results in recent clinical trials. While some research indicates a potential acceleration of agin...
QuantumBio Therapeutics, a pioneering firm at the intersection of quantum mechanics and biological research, has announced the successful closure of a $750 million Series D funding round. The signific...
Recent discussions, notably highlighted by physicist and Genomic Prediction co-founder Steve Hsu, underscore the burgeoning market for polygenic embryo screening (PES) within in vitro fertilization (I...
Dr. George Church, a pioneering molecular engineer and Professor of Genetics at Harvard Medical School, has articulated a vision where biotechnology could enable humans to reach "escape velocity" from...
**Seoul, South Korea** – A novel deep learning model, Cancer Drug Response Profile scan (CDRscan), has demonstrated remarkable accuracy, achieving an R² value exceeding 0.84 and an AUROC over 0.98, in...
